No abstract

BackgroundProton pump inhibitors (PPIs) are used for the treatment and prophylaxis of variety of acid peptic conditions including stress ulcers. There has been a persistent practice of their inappropriate use for stress ulcer prophylaxis. Purpose of our study was to measure the inappropriate use of Intravenous Proton Pump Inhibitors for stress ulcer prophylaxis and to estimate the financial burden.MethodsWe carried out a retrospective, analytic study from July 2008 to June 2009 in internal medicine department. Hospital pharmacy records were used to identify all patients who received IV PPI during hospital stay. Seventy-five percent of records were randomly chosen (n=1104). PPI application was defined as indicated according to AGA guidelines.ResultsIntravenous proton pump inhibitor (IV PPI) was prescribed for 68.5% of patients without any proper indication. The estimated cost of medication for inappropriate IV PPIS use during the study year was 18337 USD.ConclusionsA more rational use of PPI will have better impact on health care cost and is likely to add to patient safety.KeywordsInappropriate use of PPI; Stress ulcer prophylaxis; Healthcare cost

We present a case of a 25-year-old Hispanic woman who presented to emergency department with chief complaint of left lower quadrant abdominal pain. Initial workup revealed positive pregnancy test. Serum human chorionic gonadotropin was 36,478 (normal range, 0 to 8.0) IU/mL. She underwent diagnostic laparoscopy with dilatation and curettage, which did not reveal any evidence of intrauterine or extrauterine pregnancy. Chest and abdomen radiographic findings were significant for a heterogenously enhancing 2.2×1.7×1.6 cm nodule in superior segment of the right lower lobe of the lung and a large perinephric hematoma. We performed radial endobronchial ultrasound-guided transbronchial biopsies of the right lower lobe lesion. Pathologic specimen revealed choriocarcinoma.

Introduction: Persistent pulmonary air leaks present a challenging clinical problem, often requiring surgical intervention that not all patients can withstand. Patient concerns: An elderly female with severe emphysematous Chronic Obstructive Pulmonary Disease and dependent on continuous home oxygen supplementation developed recurrent pneumothoraces. On evaluation, the patient was considered a poor surgical candidate for Video assisted thoracoscopic surgery, and therefore a less invasive approach to treat the recurrent pneumothoraces was required. Diagnosis: A diagnosis of recurrent right pneumothorax due to Pulmonary-parenchymal fistula (either alveolo-pleural fistula or broncho-pleural fistula) was made Interventions: Due to the fragile overall condition of the patient, the peri-procedure risk of video assisted thoracoscopic surgery was not acceptable. Hence bronchoscopic evaluation with an endobronchial blood patch with thrombin injection was performed using a swan-ganz catheter. Outcomes: The patient had significant reduction in air leak post procedure and achieved complete resolution on day 3. She was successfully discharged home later. Conclusion: In patients with significant comorbidities that preclude standard interventions for persistent pulmonary-pleural fistulas, endobronchial blood patch repair with thrombin injection can be safely performed utilizing a swan-ganz catheter.